Immunohistochemical testing of 535 HCC samples and adjacent nontumor (ANT) tissues revealed that the high LC3 expression in the tumor and liver microenvironments is significantly associated with lower HCC recurrence44. This evidence concerns the gene MAP1LC3A and hepatocellular carcinoma.